Contraception with an injectable progestin: A study of its use in postpartum women

摘要: Abstract A study was performed on a group of 100 postpartum women who received an injectable progestin, depo-medroxyprogesterone acetate (DMPA) for contraception. The patients 150 mg. DMPA in the immediate puerperium and at intervals 3 months thereafter. Periodic endometrial histology vaginal cytology addition to recording alterations bleeding pattern body weight. No pregnancies occurred, confirming method's effectiveness. rate continued use also good. There no significant alteration Although occurred irregularly more frequently early study, its incidence progressively decreased so that majority were amenorrheic by sixth month. atrophic endometrium steadily increased, demonstrating good correlation with pattern. consistently demonstrated low estrogen effect, there high percentage intermediate cells all times.